21 A Toolkit for Health Care Professionals Screening for Kidney Disease to Reduce CVD Risk Notes: Key for toolkit terms ACEi/ARB: angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers ACE inhibitors: angiotensin-converting enzyme ADA: American Diabetes Association AHA: American Heart Association CKD: chronic kidney disease CKM: cardiovascular-kidney-metabolic CVD: cardiovascular disease GFR: glomerular filtration rate eGFR: estimated glomerular filtration rate GDMT: guideline-directed medical therapy GLP1-RA: glucagon-like peptide-1 receptor agonists HF: heart failure MASLD: metabolic dysfunction-associated steatotic liver disease MetS: metabolic syndrome nsMRA: non-steroidal mineralocorticoid antagonists (finerenone) PAD: Peripheral artery disease SDOH: social determinants of health SGLT2i: sodium-glucose transporter-2 inhibitors T1D: type 1 diabetes T2D: type 2 diabetes uACR: urine albumin-creatinine ratio
RkJQdWJsaXNoZXIy MjI2NjI=